Stay updated on Autologous TILs in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Autologous TILs in Solid Tumors Clinical Trial page.

Latest updates to the Autologous TILs in Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedAdded recruitment status note 'No longer looking for participants' and new help/navigation sections: How to Read a Study Record, Common Questions, and How to Join a Study. Updated the header label from 'Intervention / Treatment' to 'Intervention/Treatment' and replaced the old revision tag with 'Revision: v3.6.0'.SummaryDifference0.3%

- Check17 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, signaling a minor update to the study page without changes to its data.SummaryDifference0.0%

- Check39 days agoChange DetectedNew content adds a concluding statement on events for evaluating study endpoints and expands details about lifileucel-based TIL therapies and their regimens across cohorts. It also updates enrollment numbers (225), location count (34), eligibility criteria, and recruitment status, while removing some contact information and older location listings.SummaryDifference6%

- Check60 days agoChange DetectedThe page’s footer revision/version indicator has been updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check67 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check96 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed.SummaryDifference0.0%

Stay in the know with updates to Autologous TILs in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Autologous TILs in Solid Tumors Clinical Trial page.